Sarah Little to Cost-Benefit Analysis
This is a "connection" page, showing publications Sarah Little has written about Cost-Benefit Analysis.
Connection Strength
1.017
-
Assess the 'value' of a healthcare intervention, not just its price: Study design: economic evaluation. BJOG. 2019 Mar; 126(4):525.
Score: 0.599
-
Cost-effectiveness of elective induction of labor at 41 weeks in nulliparous women. Am J Obstet Gynecol. 2011 Feb; 204(2):137.e1-9.
Score: 0.088
-
The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol. 2010 Mar; 202(3):253.e1-7.
Score: 0.084
-
Cost of transferring one through five embryos per in vitro fertilization cycle from various payor perspectives. Obstet Gynecol. 2006 Sep; 108(3 Pt 1):593-601.
Score: 0.066
-
Acyclovir prophylaxis for pregnant women with a known history of herpes simplex virus: a cost-effectiveness analysis. Am J Obstet Gynecol. 2005 Sep; 193(3 Pt 2):1274-9.
Score: 0.062
-
The uninsured and the benefits of medical progress. Health Aff (Millwood). 2003 Jul-Aug; 22(4):210-9.
Score: 0.053
-
A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families. Fam Cancer. 2011 Sep; 10(3):535-43.
Score: 0.023
-
The financial effects of expanding postpartum contraception for new immigrants. Obstet Gynecol. 2010 Mar; 115(3):552-558.
Score: 0.021
-
Maternal and neonatal outcomes of elective induction of labor. Evid Rep Technol Assess (Full Rep). 2009 Mar; (176):1-257.
Score: 0.020